ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 8, 2011, Pages 1665-1672

  Nakao, Makoto ^a,b   Matsuo, Keitaro ^a,c   Ito, Hidemi ^a   Shitara, Kohei ^a   Hosono, Satoyo ^a   Watanabe, Miki ^a   Ito, Seiji ^a   Sawaki, Akira ^a   Iida, Shinsuke ^b   Sato, Shigeki ^b   Yatabe, Yasushi ^a   Yamao, Kenji ^a   Ueda, Ryuzo ^b   Tajima, Kazuo ^a   Hamajima, Nobuyuki ^c   Tanaka, Hideo ^a,c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN;

ADULT; AGED; ALLELE; ARTICLE; ATROPHIC GASTRITIS; BLOOD GROUP ABO SYSTEM; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STOMACH CANCER;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GASTRITIS, ATROPHIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELICOBACTER INFECTIONS; HUMANS; JAPAN; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 79961241629     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0213     Document Type: Article

References (49)

1. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 2009;39:850-8.
2. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006;12:354-62. (Pubitemid 43329250)
3. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009;472:467-77.
4. Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010;172:1280-5.
5. Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J 1953;1:799-801.
6. Lee HH, Wu HY, Chuang YC, Chang AS, Chao HH, Chen KY, et al. Epidemiologic characteristics and multiple risk factors of stomach cancer in Taiwan. Anticancer Res 1990;10:875-81.
7. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995;333:32-41.
8. El H II, Hashash JG, Baz EM, Abdul-Baki H, Sharara AI. ABO blood group and gastric cancer: rekindling an old fire? South Med J 2007;100:726-7. (Pubitemid 47056527)
9. Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB. ABO blood group and cancer. Eur J Cancer 2010;46:3345-50.
10. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986-90.
11. Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 2010;70:1015-23.
12. Wolpin BM, Kraft P, Xu M, Steplowski E, Olsson ML, Arslan AA, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev 2010;19:3140-9.
13. Shibata A, Hamajima N, Ikehara Y, Saito T, Matsuo K, Katsuda N, et al. ABO blood type, Lewis and Secretor genotypes, and chronic atrophic gastritis: a cross-sectional study in Japan. Gastric Cancer 2003;6:8-16. (Pubitemid 36460551)
14. Miwa H, Go MF, Sato NH. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 2002;97:1106-12. (Pubitemid 34478107)
15. Adamu MA, Weck MN, Gao L, Brenner H. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol 2010;25:439-48.
16. Konturek PC, Konturek SJ, Brzozowski T. Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol 2009;60:3-21.
17. Tajima K, Hirose K, Inoue M, Takezaki T, Hamajima N, Kuroishi T. A model of practical cancer prevention for out-patients visiting a hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Asian Pac J Cancer Prev 2000;1:35-47.
18. Hamajima N, Matsuo K, Saito T, Hirose K, Inoue M, Takezaki T, et al. Gene-environment interactions and polymorphism studies of cancer risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev 2001;2:99-107.
19. Inoue M, Tajima K, Hirose K, Hamajima N, Takezaki T, Kuroishi T, et al. Epidemiological features of first-visit outpatients in Japan: comparison with general population and variation by sex, age, and season. J Clin Epidemiol 1997;50:69-77. (Pubitemid 27089209)
20. Suzuki K. ABO blood group alleles and genetic recombination. Leg Med (Tokyo) 2005;7:205-12. (Pubitemid 40828857)
21. Ogata S, Katagiri H, Kobayashi M, Ui H, Yoshii T. An examination by TaqMan PCR method with a specific probe on ABO blood typing. Jpn J Forensic Sci Technol 2007;12:167-76.
22. Nishimukai H, Fukumori Y, Tsujimura R, Okiura T, Tanabe R, Orimoto C, et al. Rare alleles of the ABO blood group system in two European populations. Leg Med (Tokyo). 2009;11 Suppl 1:S479-81.
23. Kobayashi K, Iwasaki M, Anan K, Suzuki Y, Suzuki H, Tamai S, et al. An analysis of polymorphism for ABO blood group genes in a Japanese based on polymerase chain reaction. Anthropological Sci 1999;107:109-21.
24. Livak KJ. Allelic discrimination using fluorogenic probes and the 50 nuclease assay. Genet Anal 1999;14:143-9. (Pubitemid 29095371)
25. Inoue M, Kobayashi S, Matsuura A, Hamajima N, Tajima K, Tominaga S. Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis. Cancer Epidemiol Biomarkers Prev 1998;7:261-3. (Pubitemid 28353939)
26. Fukuda S, Shimoyama T, Umegaki N, Mikami T, Nakano H, Munakata A. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 2004;39:827-30. (Pubitemid 39409662)
27. Sasazuki S, Inoue M, Iwasaki M, Otani T, Yamamoto S, Ikeda S, et al. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2006;15:1341-7. (Pubitemid 44125292)
28. Fukumori Y, Ohnoki S, Shibata H, Nishimukai H. Suballeles of the ABO blood group system in a Japanese population. Hum Hered 1996;46:85-91. (Pubitemid 26059452)
29. Aird I, Lee DR, Roberts JA. ABO blood groups and cancer of oesophagus, cancerof pancreas, and pituitary adenoma. Br Med J 1960;1:1163-6.
30. Vogel F. Controversy in human genetics. ABO blood groups and disease. Am J Hum Genet 1970;22:464-75.
31. Mentis A, Blackwell CC, Weir DM, Spiliadis C, Dailianas A, Skandalis N. ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers. Epidemiol Infect 1991;106:221-9.
32. Loffeld RJ, Stobberingh E. Helicobacter pylori and ABO blood groups. J Clin Pathol 1991;44:516-7.
33. Boren T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 1993;262:1892-5. (Pubitemid 24041864)
34. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009;101:424-31.
35. Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010;102:502-5.
36. Tatemichi M, Sasazuki S, Inoue M, Tsugane S. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen. Acta Oncol 2008;47:360-5. (Pubitemid 351414940)
37. Szulman AE. The Histological Distribution of the Blood Group Substances in Man as Disclosed by Immunofluorescence: II. The H Antigen and Its Relation to a and B Antigens. J Exp Med 1962;115:977-96.
38. Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1999;1473:247-66.
39. Hakomori S. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol 2001;491:369-402. (Pubitemid 32595136)
40. Wiggins KL, Smith NL, Glazer NL, Rosendaal FR, Heckbert SR, Psaty BM, et al. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost 2009;7:263-9.
41. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010;19:1863-72.
42. Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008;4:e1000118.
43. Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, Rafferty I, et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 2008;4:e1000072.
44. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE, et al. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble Eselectin. Arterioscler Thromb Vasc Biol 2009;29:1958-67.
45. Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, Sun Q, et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 2010;19:1856-62.
46. Yip SP. Single-tube multiplex PCR-SSCP analysis distinguishes 7 common ABO alleles and readily identifies new alleles. Blood 2000;95:1487-92. (Pubitemid 30099865)
47. Gassner C, Schmarda A, Nussbaumer W, Schonitzer D. ABO glycosyltransferase genotyping by polymerase chain reaction using sequence-specific primers. Blood 1996;88:1852-6. (Pubitemid 26307084)
48. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-43. (Pubitemid 38160674)
49. Matsuo K, Tajima K, Suzuki T, Kawase T, Watanabe M, Shitara K, et al. Association of prostate stem cell antigen gene polymorphisms with the risk of stomach cancer in Japanese. Int J Cancer 2009;125:1961-4.